Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion description "[HCT-116 cells, a human model of colon cancer, which are highly metastatic and undifferentiated, were treated with LY294002, a specific inhibitor of PI3K.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion evidence source_evidence_literature NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion SIO_000772 20204404 NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion wasDerivedFrom befree-20140225 NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_assertion wasGeneratedBy ECO_0000203 NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP722733.RAHDWuqUhPtcwsWNc3yV_mBMxBjma-Y4Ry8CFQP_bRpnE130_provenance.